No Cost for Monkeypox Testing Act of 2022

12/29/2022, 7:03 PM

Summary of Bill HR 8693

Bill 117 hr 8693, also known as the No Cost for Monkeypox Testing Act of 2022, was introduced in the US Congress with the aim of providing free testing for monkeypox, a rare viral disease that can be transmitted to humans from animals. The bill seeks to ensure that individuals who may have been exposed to monkeypox are able to access testing without incurring any out-of-pocket costs.

If passed, the No Cost for Monkeypox Testing Act of 2022 would require health insurance plans to cover the cost of testing for monkeypox, including any necessary follow-up care. This would help to ensure that individuals who may have been exposed to the virus are able to receive timely testing and treatment, reducing the risk of further transmission.

The bill has garnered bipartisan support in Congress, with lawmakers from both parties recognizing the importance of ensuring that individuals have access to affordable testing for infectious diseases like monkeypox. Supporters of the bill argue that providing free testing for monkeypox will help to protect public health and prevent the spread of the virus within the United States. Overall, the No Cost for Monkeypox Testing Act of 2022 aims to address a pressing public health issue by ensuring that individuals who may have been exposed to monkeypox are able to access testing without facing financial barriers. If passed, the bill has the potential to improve the detection and containment of monkeypox outbreaks, ultimately benefiting the health and well-being of the American public.

Congressional Summary of HR 8693

No Cost for Monkeypox Testing Act of 2022

This bill requires specified public health care programs and private health insurance to cover, through December 31, 2023, testing for monkeypox without imposing cost-sharing, including deductibles, coinsurance, and copayments. (Monkeypox is a viral disease that is endemic to parts of Africa and causes symptoms similar to, but less severe than, smallpox.)

The bill also establishes procedures for uninsured individuals to access such testing at no cost.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill HR 8693

Bill HR 8693 is currently in the status of Bill Introduced since August 9, 2022. Bill HR 8693 was introduced during Congress 117 and was introduced to the House on August 9, 2022.  Bill HR 8693's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of August 9, 2022

Bipartisan Support of Bill HR 8693

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
50
Democrat Cosponsors
50
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 8693

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 8693

No Cost for Monkeypox Testing Act of 2022No Cost for Monkeypox Testing Act of 2022To ensure access to cost-free monkeypox testing services.
Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 8693

R
Sean Patrick Maloney
New York(Democrat)
R
Jennifer Wexton
Virginia(Democrat)
R
Peter Welch
Vermont(Democrat)
R
Nydia M. Velázquez
New York(Democrat)
R
Lauren Underwood
Illinois(Democrat)

Latest Bills

SAVE Act
Bill HR 22April 2, 2025
Providing for consideration of the joint resolution (S.J. Res. 18) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions''; providing for consideration of the joint resolution (S.J. Res. 28) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to ''Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications''; providing for consideration of the bill (H.R. 1526) to amend title 28, United States Code, to limit the authority of district courts to provide injunctive relief, and for other purposes; providing for consideration of the bill (H.R. 22) to amend the National Voter Registration Act of 1993 to require proof of United States citizenship to register an individual to vote in elections for Federal office, and for other purposes; and for other purposes.
Bill HRES 282April 2, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions".
Bill SJRES 18April 2, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications".
Bill SJRES 28April 2, 2025
Providing for the consideration of the resolution (H. Res. 23) permitting parental remote voting by proxy, and for other purposes.
Bill HRES 164April 2, 2025
NORRA of 2025
Bill HR 1526April 2, 2025
Strengthening Support for American Manufacturing Act
Bill S 99April 2, 2025
American Music Tourism Act of 2025
Bill S 195April 2, 2025
ADS for Mental Health Services Act
Bill S 414April 2, 2025
A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Bill S 1040April 2, 2025